QYUNS THERAPEUTICS CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.5 HKD | -3.34% |
|
-5.82% | 0.00% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Qyuns Therapeutics Co Ltd is a China-based company mainly engaged in biopharmaceuticals. The Company is mainly engaged in biotechnology research and development of biological therapies for autoimmune and allergic diseases. The Company's business mainly covers four major disease areas, including skin, rheumatism, respiratory and digestive tract diseases. The Company is developing eight projects, with target indications including psoriasis, atopic dermatitis, rheumatoid arthritis, inflammatory bowel disease and asthma. The Company's core products include QX002N and QX005N.
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 809M | |
| +10.79% | 115B | |
| +11.65% | 106B | |
| -6.20% | 24.69B | |
| -2.33% | 21.97B | |
| -6.03% | 19.27B | |
| -13.41% | 17.56B | |
| -40.50% | 17.32B | |
| +6.64% | 14.03B | |
| +31.84% | 12.13B |
- Stock Market
- Equities
- 2509 Stock
- News Qyuns Therapeutics Co., Ltd.
- China Grants Investigational New Drug Status to Qyuns Therapeutics' Urticaria Treatment
